710-31-6 Usage
General Description
2-[(4-Fluorophenyl)amino]acetohydrazide is a chemical compound that is derived from acetohydrazide and contains a fluorophenyl substituent. It is a white to off-white solid that is slightly soluble in water and is commonly used as a reagent in organic synthesis. 2-[(4-FLUOROPHENYL)AMINO]ACETOHYDRAZIDE has been studied for its potential antimicrobial and antifungal properties, as well as its potential use in the development of new pharmaceutical drugs. It may also have applications in the field of agricultural chemistry, and as a building block for the synthesis of other organic compounds. However, further research and testing are needed to fully understand and characterize its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 710-31-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,1 and 0 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 710-31:
(5*7)+(4*1)+(3*0)+(2*3)+(1*1)=46
46 % 10 = 6
So 710-31-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H10FN3O/c9-6-1-3-7(4-2-6)11-5-8(13)12-10/h1-4,11H,5,10H2,(H,12,13)
710-31-6Relevant articles and documents
Design and synthesis of new 2,5-disubstituted-1,3,4-oxadiazole analogues as anticancer agents
Agarwal, Mohit,Singh, Vikram,Sharma, Sachin Kumar,Sharma, Piush,Ansari, Md. Yousuf,Jadav, Surender Singh,Yasmin, Sabina,Sreenivasulu, Reddymasu,Hassan, Mohd. Zaheen,Saini, Vipin,Ahsan, Mohamed Jawed
, p. 2289 - 2303 (2016/10/25)
In continuance of our search for new anticancer agents, we report herein the design, synthesis, and anticancer evaluation of oxadiazole analogues. Two series (4a-h and 4i-q) of new oxadiazole analogues were designed based on heterocyclic (1,3,4-oxadiazole
Ion Channel Modulators
-
Page/Page column 38, (2010/11/29)
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of ion channel function, and treatment of disease and disease symptoms, particularly those mediated by certain calcium channel subtype targets.